FDG PET或PET/CT与FDG PET/MR在炎症性肠病中诊断价值的比较——一项系统综述与Meta分析
该系统综述与Meta分析通过PubMed检索截至2024年3月14日的文献,纳入14项研究,比较FDG PET(PET/CT)与FDG PET/MR在炎症性肠病(IBD)中的诊断价值。基于肠段的合并分析显示,两者在检出或排除IBD方面无显著差异,均表现出较高的诊断性能。
要点
- FDG PET(PET/CT)诊断IBD的基于肠段合并敏感度为0.81、特异度为0.86。
- FDG PET/MR诊断IBD的基于肠段合并敏感度为0.78、特异度为0.92。
- FDG PET(PET/CT)与FDG PET/MR在检出或排除IBD的能力上无显著差异。
核心结论
- 在IBD患者中,FDG PET(PET/CT)与FDG PET/MR的诊断价值无显著差异,两者均对准确诊断IBD表现出较高的诊断性能。
研究设计与样本
- 按照系统综述与Meta分析首选报告条目(PRISMA)声明,在PubMed检索自建库至2024年3月14日报告FDG PET(PET/CT)与FDG PET/MR在IBD中诊断性能的研究,共纳入14项研究进行系统综述与Meta分析。
主要发现
- FDG PET(PET/CT)诊断IBD(9项研究)的基于肠段合并敏感度为0.81、特异度为0.86、阳性似然比为5.76、阴性似然比为0.22、诊断比值比为31.92、SROC曲线下面积为0.92。
- FDG PET/MR诊断IBD(5项研究)的基于肠段合并敏感度为0.78、特异度为0.92、阳性似然比为10.97、阴性似然比为0.25、诊断比值比为51.79、SROC曲线下面积为0.95。
- FDG PET(PET/CT)与FDG PET/MR在检出或排除IBD的能力上无显著差异。
关键数值与推荐
- FDG PET(PET/CT)诊断IBD的基于肠段合并敏感度0.81、特异度0.86、阳性似然比5.76、阴性似然比0.22、诊断比值比31.92、SROC曲线下面积0.92。
- FDG PET/MR诊断IBD的基于肠段合并敏感度0.78、特异度0.92、阳性似然比10.97、阴性似然比0.25、诊断比值比51.79、SROC曲线下面积0.95。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to compare the diagnostic value of 18 F-FDG PET or PET/CT with FDG PET/MR in patients with inflammatory bowel disease (IBD). METHODS: A comprehensive search was performed in PubMed for studies reporting the diagnostic performance of FDG PET (PET/CT) and FDG PET/MR in IBD from the inception of the database to March 14, 2024, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Fourteen studies were included in this systematic review and meta-analysis. Pooled estimates of segment-based sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio for FDG PET (PET/CT) and FDG PET/MR were calculated alongside 95% confidence intervals. Summary receiver operating characteristic (SROC) curves were plotted, and the area under the SROC curve was determined alongside the Q * index. RESULTS: The segment-based pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and area under the SROC curve of FDG PET (PET/CT) for diagnosing IBD (9 studies) were 0.81, 0.86, 5.76, 0.22, 31.92, and 0.92, respectively. Those of FDG PET/MR (5 studies) were 0.78, 0.92, 10.97, 0.25, 51.79, and 0.95. There was no significant difference in the abilities of detecting or excluding IBD between FDG PET (PET/CT) and FDG PET/MR. CONCLUSIONS: For diagnostic value in patients with IBD, there was no significant difference between FDG PET (PET/CT) and FDG PET/MR. Both FDG PET (PET/CT) and FDG PET/MR have demonstrated high diagnostic performance for accurate diagnosing in patients with IBD.
引用
- Lin CY, Chang MC, Kao CH, et al. Comparing the Diagnostic Value of FDG PET or PET/CT With FDG PET/MR in Inflammatory Bowel Disease-A Systematic Review and Meta-analysis. Clin Nucl Med. 2024. PMID: 38973081. doi:10.1097/RLU.0000000000005379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。